Jon Lamb intention to retire

AFT Pharmaceuticals Limited, Level 1, 129 Hurstmere Road, Takapuna, Auckland 0622, New Zealand
Incorporated in New Zealand ARBN:
ARBN 609 017 969 investor.relations@aftpharm.com





4 August 2023

Retirement of Jon Lamb

AFT Pharmaceuticals (NZX.AFT, ASX.AFP) independent director Jon Lamb has
announced his intention to retire as a director of the company, following the
recruitment and appointment of a replacement independent director to the Board.
Chair David Flacks said: “On behalf of the Board I would like to extend my thanks to
Jon for his outstanding service during his 11-year tenure. His deep industry knowledge
and experience has enabled him to make a significant contribution to the growth
and success of AFT, and it has been a privilege to work alongside him.”
The Board will now commence a recruitment process for a replacement director, and
further details will be announced in due course.

Released for and on behalf of AFT Pharmaceuticals limited by Malcolm Tubby, Chief
Financial Officer.


For more information:
Investors Media
Dr Hartley Atkinson Richard Inder
Managing Director The Project
AFT Pharmaceuticals Tel: +64 21 645 643
Tel: +64 9488 0232

About AFT Pharmaceuticals (ASX:AFP, NZX:AFT)
www.aftpharm.com
AFT Pharmaceuticals are a growing multinational pharmaceutical company that
develops, markets, and distributes a broad portfolio of pharmaceutical products
across a wide range of therapeutic categories which are distributed across all major
pharmaceutical distribution channels: over the counter, prescription, and hospital.
AFT Pharmaceutical's product portfolio comprises both proprietary and in -licensed
products, and includes patented, branded, and generic drugs.